BIO's lobbying chief departs against backdrop of China-US biosecurity concerns, drug price reckoning
BIO's lobbying chief departs against backdrop of China-US biosecurity concerns, drug price reckoning fkansteiner Wed, 04/10/2024 - 14:51
BIO's lobbying chief departs against backdrop of China-US biosecurity concerns, drug price reckoning fkansteiner Wed, 04/10/2024 - 14:51
How CDMO’s are addressing cold chain needs with specialized solutions jpiatt Wed, 04/10/2024 - 14:00
API Innovation Center looks to bolster US cancer drug supplies with Apertus deal, new tech jkeenan Wed, 04/10/2024 - 11:54
Novartis halts recruitment of Kisqali trials as it adjusts production methods kdunleavy Wed, 04/10/2024 - 11:10
FDA appears receptive to surrogate endpoint supporting accelerated approval of multiple myeloma drugs aliu Wed, 04/10/2024 - 10:55
Leading AstraZeneca investor defends CEO pay ahead of shareholder vote: FT zbecker Wed, 04/10/2024 - 10:49
FDA lambasts Kilitch for unsanitary manufacturing conditions and issues warning letter to Natco, too fkansteiner Wed, 04/10/2024 - 09:46